Biovista Inc. is a private drug development services company based in Charlottesville, Virginia, US.
Biovista is also applying its technology platform to develop its own drug repositioning programs in the areas of central nervous system (CNS), diabetes/obesity, eye disorders, and oncology.
Biovista is also creating software-based tools and services for Reagent companies, researchers in the Life sciences and the consumer and patient health areas.
Biovista Inc.’s technology platform integrates literature-based discovery algorithms with Semantic search technologies to identify and rank potential solutions to a variety of drug development related problems such as predicting the adverse events of compounds, identifying suitable biomarkers for diseases and discovering new indications for existing drugs or drug combinations.
Since the beginning of 2009, Biovista has started its own drug development programs based on repositioned compounds in CNS diseases, such as Multiple sclerosis[4][5] and Epilepsy[6].